| Photo Gallery | Cuiabá, Brazil, 2016
Part of a narrative storytelling project developed for the Drugs for Neglected Diseases initiative, an international not-for-profit health organization.
350 million people in 98 countries are at risk of contracting leishmaniasis, a disease caused by Leishmania, a parasyte transmitted by sandflies. Although there has been some progress in drug development, especially for visceral leishmaniasis (also known as kala-azar), current drugs remain expensive, toxic, difficult to administer, or ill-suited for use in remote areas. There is a lack of adequate treatment in Africa and Latin America. While there are some treatments recommended by WHO, sustainable access to treatment is not widely available in endemic countries.